Central Administration of Human Opiorphin Alleviates Dextran Sodium Sulfate-induced Colitis in Mice Through Activation of the Endogenous Opioid System

Overview

Journal Front Pharmacol

Date 2022 Sep 30

PMID 36176442

Authors

Pan Luo

Xuelin Li

Yuan Gao

Zhengjun Chen

Quanwei Zhang

Zhimin Wang

Xiaozhu Tian

Affiliations

Soon will be listed here.

Abstract

The opioid system plays a crucial role in maintaining gastrointestinal homeostasis. Endogenous opioid peptide enkephalins have anti-inflammatory effect and participate in the treatment of inflammatory bowel diseases (IBDs). Here, we investigated the effect of natural enkephalinase inhibitor human opiorphin (HO) on dextran sodium sulfate (DSS)-induced colitis in mice. Our results showed that central administration of HO attenuated DSS-induced colitis, as indicated by the reduction of disease activity index (DAI) scores, macroscopic scores, histological scores, and the myeloperoxidase (MPO) activity. Moreover, HO alleviated DSS-induced inflammation by decreasing inflammatory cytokines TNF-α, IL-6, and IL-1β, and increasing anti-inflammatory cytokine IL-10 in both serum and colon tissues in DSS-treated mice. The potential anti-inflammatory effect of HO at a dose of 40 μg/kg was observed as evidenced by a decrease in nuclear factor κB (NF-κB) p65, toll-like receptor-4 (TLR-4), iNOS, and COX-2. HO also improved intestinal barrier function by enhancing the expression of tight junction proteins. Furthermore, HO treatment significantly inhibited activities of neutral endopeptidase (NEP) and aminopeptidase N (APN), elevated serum enkephalins concentrations, and increased expressions of mu and delta opioid receptors. In addition, pretreatment with opioid receptor antagonist naloxone hydrochloride (NH) compromised the protective effect of HO and aggravated colitis symptoms, as indicated by inhibited anti-inflammatory effects, disrupted intestinal barrier function, and decreased opioid receptor activity. In conclusion, these data indicate that HO protects against DSS-induced colitis by inhibiting TLR4/NF-κB pathway activation and improving intestinal barrier function through activation of the endogenous opioid system. Therefore, targeting the opioid system with peptidase inhibitors intervention would be a novel strategy in the therapy of IBD.

Citing Articles

Natural Flavonoid-Derived Enzyme Mimics DHKNase Balance the Two-Edged Reactive Oxygen Species Function for Wound Healing and Inflammatory Bowel Disease Therapy.

Feng G, Zhang H, Liu H, Zhang X, Jiang H, Liao S Research (Wash D C). 2024; 7:0464.

PMID: 39253100 PMC: 11381673. DOI: 10.34133/research.0464.

Opiorphin: an endogenous human peptide with intriguing application in diverse range of pathologies.

Tiwari C, Khan H, Grewal A, Dhankhar S, Chauhan S, Dua K Inflammopharmacology. 2024; 32(5):3037-3056.

PMID: 39164607 DOI: 10.1007/s10787-024-01526-8.

Significance of CD10 for Mucosal Immunomodulation by β-Casomorphin-7 in Exacerbation of Ulcerative Colitis.

Miyagawa Y, Fujiwara-Tani R, Ikemoto A, Sasaki R, Ogata R, Nishiguchi Y Curr Issues Mol Biol. 2024; 46(7):6472-6488.

PMID: 39057028 PMC: 11276523. DOI: 10.3390/cimb46070386.

Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and control subjects.

Alajbeg I, Vrbanovic E, Alajbeg I, Orabovic I, Naka K, Mrla A Clin Oral Investig. 2024; 28(5):246.

PMID: 38589630 DOI: 10.1007/s00784-024-05653-y.

Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease?.

Li L, Peng P, Ding N, Jia W, Huang C, Tang Y Antioxidants (Basel). 2023; 12(4).

PMID: 37107341 PMC: 10135842. DOI: 10.3390/antiox12040967.

References

Dietis N, Rowbotham D, Lambert D . Opioid receptor subtypes: fact or artifact?. Br J Anaesth. 2011; 107(1):8-18. DOI: 10.1093/bja/aer115. View

Ungaro R, Mehandru S, Allen P, Peyrin-Biroulet L, Colombel J . Ulcerative colitis. Lancet. 2016; 389(10080):1756-1770. PMC: 6487890. DOI: 10.1016/S0140-6736(16)32126-2. View

Thomas J, Lui L, Abell A, Tieu W, Somogyi A, Bajic J . Toll-like receptors change morphine-induced antinociception, tolerance and dependence: Studies using male and female TLR and signalling gene KO mice. Brain Behav Immun. 2022; 102:71-85. DOI: 10.1016/j.bbi.2022.02.001. View

Wadie W, Abdel-Aziz H, Zaki H, Kelber O, Weiser D, Khayyal M . STW 5 is effective in dextran sulfate sodium-induced colitis in rats. Int J Colorectal Dis. 2012; 27(11):1445-53. PMC: 3474908. DOI: 10.1007/s00384-012-1473-z. View

Tian X, Chen J, Xiong W, He T, Chen Q . Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in mice. Peptides. 2009; 30(7):1348-54. DOI: 10.1016/j.peptides.2009.04.002. View

Bank U, Heimburg A, Helmuth M, Stefin S, Lendeckel U, Reinhold D . Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease. Int Immunopharmacol. 2006; 6(13-14):1925-34. DOI: 10.1016/j.intimp.2006.09.014. View

Chang J . Pathophysiology of Inflammatory Bowel Diseases. N Engl J Med. 2020; 383(27):2652-2664. DOI: 10.1056/NEJMra2002697. View

Lu N, Wang L, Cao H, Liu L, Van Kaer L, Washington M . Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis. J Immunol. 2014; 192(3):1013-23. PMC: 4006992. DOI: 10.4049/jimmunol.1300133. View

Wittmann Dayagi T, Werner L, Pinsker M, Salamon N, Barschak I, Weiss B . Mucosal IL-10 and IL-10 receptor expression patterns in paediatric patients with ulcerative colitis. Int J Exp Pathol. 2021; 102(1):4-10. PMC: 7839950. DOI: 10.1111/iep.12382. View

10.

Song C, Kim N, Lee S, Nam R, Choi S, Kang S . Effects of 17β-estradiol on colorectal cancer development after azoxymethane/dextran sulfate sodium treatment of ovariectomized mice. Biochem Pharmacol. 2019; 164:139-151. DOI: 10.1016/j.bcp.2019.04.011. View

11.

Yamamoto Y, Kanazawa H, Shimamura M, Ueki M, Hazato T . Inhibitory action of spinorphin, an endogenous regulator of enkephalin-degrading enzymes, on carrageenan-induced polymorphonuclear neutrophil accumulation in mouse air-pouches. Life Sci. 1998; 62(19):1767-73. DOI: 10.1016/s0024-3205(98)00138-6. View

12.

Lu Y, Li X, Liu S, Zhang Y, Zhang D . Toll-like Receptors and Inflammatory Bowel Disease. Front Immunol. 2018; 9:72. PMC: 5797585. DOI: 10.3389/fimmu.2018.00072. View

13.

Tian X, Chen Y, Bai L, Luo P, Du X, Chen Q . Effects and underlying mechanisms of human opiorphin on cardiovascular activity in anesthetized rats. Eur J Pharmacol. 2014; 749:32-8. DOI: 10.1016/j.ejphar.2014.11.025. View

14.

Vergnolle N . Protease inhibition as new therapeutic strategy for GI diseases. Gut. 2016; 65(7):1215-24. PMC: 4941139. DOI: 10.1136/gutjnl-2015-309147. View

15.

Kiesler P, Fuss I, Strober W . Experimental Models of Inflammatory Bowel Diseases. Cell Mol Gastroenterol Hepatol. 2015; 1(2):154-170. PMC: 4435576. DOI: 10.1016/j.jcmgh.2015.01.006. View

16.

Wang H, Li Y, Niu Y, Zheng J, Wu J, Shi G . Observing Anti-inflammatory and Anti-nociceptive Activities of Glycyrrhizin Through Regulating COX-2 and Pro-inflammatory Cytokines Expressions in Mice. Inflammation. 2015; 38(6):2269-78. DOI: 10.1007/s10753-015-0212-3. View

17.

Gerova V, Stoynov S, Katsarov D, Svinarov D . Increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test. World J Gastroenterol. 2011; 17(17):2211-5. PMC: 3092873. DOI: 10.3748/wjg.v17.i17.. View

18.

van der Gracht E, Zahner S, Kronenberg M . When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD. Mediators Inflamm. 2016; 2016:9765238. PMC: 4989064. DOI: 10.1155/2016/9765238. View

19.

Boehm F, Martin M, Kesselring R, Schiechl G, Geissler E, Schlitt H . Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation. BMC Gastroenterol. 2012; 12:97. PMC: 3449180. DOI: 10.1186/1471-230X-12-97. View

20.

Bai T, Song C, Zheng C, Huang G . Acupuncture for the treatment of functional constipation. J Tradit Chin Med. 2018; 36(5):578-87. DOI: 10.1016/s0254-6272(16)30076-0. View